Matthew R. Medcalf, PhD (he/him/his)

Iktos, Massachusetts, United States

Matthew Medcalf is a synthetic organic chemist by training, completing his PhD in 2019 at Washington University in St. Louis where his thesis focused on the synthesis of cyclic depsipeptide macrocycles. Upon graduation, Matthew transitioned to medicinal chemistry as a postdoctoral research associate at Washington University School of Medicine, where he engaged in multiple projects to develop small molecule drugs towards a wide variety of disease indications. As an applications scientist at Iktos, Matthew leverages his experience in synthetic organic chemistry and medicinal chemistry to share advances in the application of AI to accelerate drug discovery and manage research collaborations.

Disclosure information not submitted.

Presentation(s):

• Empowering Humans: Integrating AI and Robotics for Efficient Drug Design and Discovery

  Wednesday, February 7, 2024
  1:30 PM – 2:00 PM EST